EDI

John Bell

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute

Professor, Depts. of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa

Program Director, Ontario Regional Biotherapeutics Program(ORBiT), Ontario Institute for Cancer Research, OICR

Director, Canadian Oncolytic Virus Consortium (COVCo), Terry Fox New Frontiers Program Project Grant

Scientific Director, BioCanRx, Biotherapeutics for Cancer Treatment, Network of Centres of Excellence (NCE)

Research Interests and Clinical Approach

Our research program is directed towards the identification and characterization of novel cancer killing therapeutic viruses that selectively infect and kill cancer cells, while leaving healthy cells and tissues unharmed. Not only do we discover and design new therapeutic viruses, but we also manufacture them for eventual clinical translation and commercialization.